Kari C. Nadeau
Affiliate - Stanford Woods Institute for the Environment;Naddisy Foundation Professor of Pediatric Food Allergy, Immunology and Asthma, Professor of Pediatrics (Allergy & Clinical Immunology) and, by courtesy, of Otolaryngology-Head & Neck Surgery at the
Dr. Kari Nadeau is one of the nation’s foremost experts in adult and pediatric allergy and asthma. She is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Section Chief of Allergy and Asthma at the Stanford School of Medicine, and an endowed professor under the Naddisy Family Foundation.
Dr. Nadeau received her MD and PhD from Harvard Medical School, completed a residency in pediatrics at Boston Children’s Hospital and a clinical fellowship in asthma and immunology at Stanford. After completing her residency, she spent 5 years in the biopharmaceutical industry, where she was instrumental in obtaining FDA approval for two biologics in the ﬁelds of autoimmunity and oncology, before starting her fellowship at Stanford.
Dr. Nadeau has received honors and awards from the American Academy of Allergy, Asthma & Immunology; the American Lung Association; the Clinical Immunological Society; Food Allergy Research & Education (FARE); and the NIH. She has also been recognized with the U.S. Environmental Protection Agency’s STAR Grant Award. Dr. Nadeau has served as a reviewer for NIH Study Sections, and a member of the American Lung Association Medical Board, CA. She serves on the Environmental Health Policy committee for the American Thoracic Society and is a Fellow in the American Academy of Allergy, Asthma and Immunology as well as a member of ASCI (American Society of Clinical Investigation).
She has authored or co-authored more than 100 original papers. Her research focuses on understanding the factors responsible for the increased prevalence of allergies and asthma in the population, improving diagnostics, and understanding the immunological mechanisms underlying these diseases. She was the first to successfully desensitize individuals to more than one allergy at a time using multi-allergen oral immunotherapy. She continues to push forward with innovative clinical research using novel antibodies, peptide vaccines, and nanoparticles in order to provide safe and effective therapeutic options for those with allergies and asthma.